BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Martini DJ, Jansen CS, Harik LR, Evans ST, Olsen TA, Master VA, Kissick HT, Bilen MA. Case Report: Exceptional Response to Nivolumab Plus Ipilimumab in a Young Woman With TFE3-SFPQ Fusion Translocation-Associated Renal Cell Carcinoma. Front Oncol 2021;11. [DOI: 10.3389/fonc.2021.793808] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Bai Y, Wang X, Liu Y, Ji H, Liu Z, Sun J, Zhang H. Pembrolizumab combined with Axitinib in ASPSCR1-TFE3 gene fusion translocation renal cell carcinoma: a case report and literature review.. [DOI: 10.21203/rs.3.rs-2101971/v1] [Reference Citation Analysis]
2 Ipilimumab/nivolumab. Reactions Weekly 2022;1891:173-173. [DOI: 10.1007/s40278-022-09425-6] [Reference Citation Analysis]